Pfizer announced earnings per share of $0.8 on revenue of $12.03B. Analysts polled by Investing.com anticipated EPS of $0.7 on revenue of $11.34B. That with comparison to EPS of $0.85 on revenue of $13.12B in the same period a year before. Pfizer had reported EPS of $0.55 on revenue of $12.69B in the previous quarter. Analysts are expecting EPS of $0.68 and revenue of $11.49B in the upcoming quarter.
Pfizer shares are down 7% from the beginning of the year , still down 13.98% from its 52 week high of $44.56 set on July 3, 2019. They are outperforming the S&P 500 which is down 11.29% year to date.
Pfizer’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Novartis ADR had beat expectations on Tuesday with first quarter EPS of $1.56 on revenue of $12.28B, compared to forecast for EPS of $1.37 on revenue of $11.99B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar